利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

27 条记录 (耗时 0.012 秒)

    Urinary CA125 peptides as biomarkers of ovarian cancer
    1.
    发明授权
    Urinary CA125 peptides as biomarkers of ovarian cancer 有权
    尿CA125肽作为卵巢癌生物标志物

    公开(公告)号：US08642347B2

    公开(公告)日：2014-02-04

    申请号：US12865508

    申请日：2009-01-30

    申请人： Bin Ye ,  Daniel Cramer

    发明人： Bin Ye ,  Daniel Cramer

    IPC分类号： G01N33/574 ,  G01N33/53 ,  G01N33/00 ,  C12P21/04 ,  A61K38/00 ,  C07K1/00

    CPC分类号： G01N33/57449 ,  C07K14/4748

    摘要： The present invention is directed to diagnostic methods based upon the detection of peptides derived from the degradation of CA125. In particular, it is concerned with assays of urine samples collected from women for the purpose of determining whether they are at increased risk for having ovarian cancer, have decreased their risk as the result of clinical or non-clinical procedures, to monitor the efficacy of a treatment method, or to determine whether cancer has recurred or advanced.

    摘要翻译： 本发明涉及基于检测衍生自CA125降解的肽的诊断方法。 特别地，它涉及从妇女收集的尿液样品的测定，以确定它们是否具有增加的患有卵巢癌的风险，降低其作为临床或非临床程序的结果的风险，以监测其功效 治疗方法，或确定癌症是否复发或进展。